Tedizolid Prolonged Treatment for Prosthetic Joint Infections
NCT03378427
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Prosthetic Joint Infection
Interventions
DRUG:
Tedizolid Phosphate 200 MG [Sivextro]
Sponsor
Tourcoing Hospital
Collaborators
[object Object]